Displaying drugs 4476 - 4500 of 10528 in total
Diaziquone
Investigational
Matched Iupac: … ethyl N-[2,5-bis(aziridin-1-yl)-4-[(ethoxycarbonyl)amino]-3,6-dioxocyclohexa-1,4-dien-1-yl]carbamate …
Rusfertide
Rusfertide is a hepcidin mimetic currently being developed by Protagonist Therapeutics for the treatment of polycythemia vera and beta-thalassemia.
Investigational
4,5-Dehydro-L-Iduronic Acid
Experimental
Matched Name: … 4,5-Dehydro-L-Iduronic Acid …
Matched Iupac: … (2R,3R,4R)-2,3,4,5-tetrahydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid …
Matched Iupac: … (2R,3R,4R)-2,3,4,5-tetrahydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid …
Methylinositol
Methylinositol has been used in trials studying the treatment of Dementia and Alzheimer's Disease.
Investigational
Matched Iupac: … (1R,2S,3R,4S,5S,6S)-6-methoxycyclohexane-1,2,3,4,5-pentol …
Sophora flavescens root
Experimental
Lorigerlimab
Lorigerlimab is under investigation in clinical trial NCT05848011 (A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-resistant Prostate Cancer).
Investigational
Matched Synonyms: … DEATH 1, PD1, PD-1, CD279)) AND ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4, …
3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL
Experimental
Matched Name: … 3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL …
Matched Iupac: … (2S,3S)-3-amino-4-phenylbutan-2-ol …
Matched Iupac: … (2S,3S)-3-amino-4-phenylbutan-2-ol …
(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid
Experimental
Matched Name: … (3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid …
Matched Iupac: … (2R,3S)-2-ethyl-3-(4-methylbenzenesulfonamido)butanedioic acid …
Matched Iupac: … (2R,3S)-2-ethyl-3-(4-methylbenzenesulfonamido)butanedioic acid …
Peptide YY (1-36)
Investigational
Zalifrelimab
Zalifrelimab is under investigation in clinical trial NCT03894215 (Phase 2 Study of Anti-pd-1 Independently or in Combination With Anti-ctla-4 in Second-line Cervical Cancer).
Investigational
Matched Synonyms: … A human monoclonal antibody targeting cytotoxic T lymphocyte associated protein 4 (ctla4) ... Immunoglobulin G1-kappa, anti-(homo sapiens CTLA4 (cytotoxic tlymphocyte-associated protein 4, cd152) …
Matched Description: … clinical trial NCT03894215 (Phase 2 Study of Anti-pd-1 Independently or in Combination With Anti-ctla-4 …
Matched Description: … clinical trial NCT03894215 (Phase 2 Study of Anti-pd-1 Independently or in Combination With Anti-ctla-4 …
Mavodelpar
Investigational
Matched Synonyms: … (4-{(E)-3-(4-fluorophenyl)-3-[4-(3-morpholin-4-yl-prop-1ynyl)phenyl]allyloxy}-2-methylphenoxy)acetate …
Matched Iupac: … 2-(4-{[(2E)-3-(4-fluorophenyl)-3-{4-[3-(morpholin-4-yl)prop-1-yn-1-yl]phenyl}prop-2-en-1-yl]oxy}-2-methylphenoxy …
Matched Iupac: … 2-(4-{[(2E)-3-(4-fluorophenyl)-3-{4-[3-(morpholin-4-yl)prop-1-yn-1-yl]phenyl}prop-2-en-1-yl]oxy}-2-methylphenoxy …
5'-O-(L-Cysteinylsulfamoyl)adenosine
Experimental
Matched Synonyms: … 5'-O-(N-(L-Cysteinyl)-sulfamoyl)adenosine …
Matched Name: … 5'-O-(L-Cysteinylsulfamoyl)adenosine …
Matched Iupac: … (2R)-2-amino-1-[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}sulfonyl) …
Matched Name: … 5'-O-(L-Cysteinylsulfamoyl)adenosine …
Matched Iupac: … (2R)-2-amino-1-[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}sulfonyl) …
Ergothioneine
Investigational
Matched Synonyms: … L-ergothioneine ... L-(+)-ergothioneine ... L(+)-ergothioneine …
Matched Iupac: … (2S)-3-(2-sulfanylidene-2,3-dihydro-1H-imidazol-4-yl)-2-(trimethylazaniumyl)propanoate …
Matched Iupac: … (2S)-3-(2-sulfanylidene-2,3-dihydro-1H-imidazol-4-yl)-2-(trimethylazaniumyl)propanoate …
(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine
Experimental
Matched Name: … (2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine …
Matched Iupac: … (2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine …
Matched Iupac: … (2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine …
S-Hexylglutathione
Experimental
Matched Synonyms: … S-Hexyl-L-glutathione ... S-Hexyl-glutathione …
Matched Name: … S-Hexylglutathione …
Matched Iupac: … (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-(hexylsulfanyl)ethyl]carbamoyl}butanoic acid …
Matched Name: … S-Hexylglutathione …
Matched Iupac: … (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-(hexylsulfanyl)ethyl]carbamoyl}butanoic acid …
S-Benzylcysteine
Experimental
Matched Synonyms: … L-S-Benzylcysteine ... (R)-S-Benzylcysteine …
Matched Name: … S-Benzylcysteine …
Matched Name: … S-Benzylcysteine …
Enitociclib
Investigational
Matched Synonyms: … 2-pyridinamine, 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-n-(4-(((s(s))-s-methylsulfonimidoyl)methyl)-2-pyridinyl …
Matched Iupac: … (S)-[(2-{[5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-yl]amino}pyridin-4-yl)methyl](imino)methyl-lambda6 …
Matched Iupac: … (S)-[(2-{[5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-yl]amino}pyridin-4-yl)methyl](imino)methyl-lambda6 …
MEDI-6469
MEDI-6469 is a monoclonal antibody under investigation in clinical trial NCT02205333 (A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies).
Investigational
Sparfosic acid
Sparfosic acid is a solid. This compound belongs to the n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at the terminal nitrogen atom. This substance is known to target aspartate carbamoyltransferase catalytic chain and CAD protein.
Experimental
Matched Synonyms: … N-(phosphonacetyl)-L-aspartic acid ... phosphonoacetyl-L-aspartic acid ... N-phosphonacetyl-L-aspartic acid …
(S)-alpha-methyl-4-carboxyphenylglycine
Experimental
Matched Synonyms: … (S)-a-methyl-4-carboxyphenylglycine ... (S)-α-methyl-4-carboxyphenylglycine ... (S)-(+)-α-methyl-4-carboxyphenylglycine …
Matched Name: … (S)-alpha-methyl-4-carboxyphenylglycine …
Matched Iupac: … 4-[(1S)-1-amino-1-carboxyethyl]benzoic acid …
Matched Name: … (S)-alpha-methyl-4-carboxyphenylglycine …
Matched Iupac: … 4-[(1S)-1-amino-1-carboxyethyl]benzoic acid …
Nevanimibe
Nevanimibe is under investigation in clinical trial NCT03053271 (A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome).
Investigational
Matched Iupac: … 1-[2,6-bis(propan-2-yl)phenyl]-3-({1-[4-(dimethylamino)phenyl]cyclopentyl}methyl)urea …
Displaying drugs 4476 - 4500 of 10528 in total